Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Inwards

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Blood|July 27, 2001
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphomaL F Porrata, M A Gertz, D J Inwards, et al.
Bone Marrow Transplantation|April 25, 2006
Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphomaF K Buadi, I N Micallef, S M Ansell, et al.
Leukemia|May 25, 2011
The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphomaR A Wilcox, K Ristow, T M Habermann, et al.
Bone Marrow Transplantation|March 20, 1999
Early harvest and late transplantation as an effective therapeutic strategy in multiple myelomaM A Gertz, M Q Lacy, D J Inwards, et al.
Leukemia|May 21, 2010
Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphomaL F Porrata, K Rsitow, D J Inwards, et al.
Bone Marrow Transplantation|December 17, 2003
Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphomaL F Porrata, M R Litzow, D J Inwards, et al.
Bone Marrow Transplantation|July 15, 2003
Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphomaR Howe, I N M Micallef, D J Inwards, et al.
Blood Cancer Journal|April 20, 2013
Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphomaL F Porrata, K M Ristow, T M Habermann, et al.
Leukemia|July 2, 2011
Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I studyG S Nowakowski, B LaPlant, T M Habermann, et al.
Bone Marrow Transplantation|April 11, 2006
Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemiaM A Elliott, A Tefferi, W J Hogan, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Blood|July 27, 2001
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphomaL F Porrata, M A Gertz, D J Inwards, et al.
Bone Marrow Transplantation|April 25, 2006
Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphomaF K Buadi, I N Micallef, S M Ansell, et al.
Leukemia|May 25, 2011
The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphomaR A Wilcox, K Ristow, T M Habermann, et al.
Bone Marrow Transplantation|March 20, 1999
Early harvest and late transplantation as an effective therapeutic strategy in multiple myelomaM A Gertz, M Q Lacy, D J Inwards, et al.
Leukemia|May 21, 2010
Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphomaL F Porrata, K Rsitow, D J Inwards, et al.
Bone Marrow Transplantation|December 17, 2003
Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphomaL F Porrata, M R Litzow, D J Inwards, et al.
Bone Marrow Transplantation|July 15, 2003
Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphomaR Howe, I N M Micallef, D J Inwards, et al.
Blood Cancer Journal|April 20, 2013
Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphomaL F Porrata, K M Ristow, T M Habermann, et al.
Leukemia|July 2, 2011
Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I studyG S Nowakowski, B LaPlant, T M Habermann, et al.
Bone Marrow Transplantation|April 11, 2006
Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemiaM A Elliott, A Tefferi, W J Hogan, et al.
Pageof 6